Cytokinetics
CYTK
CYTK
108 hedge funds and large institutions have $366M invested in Cytokinetics in 2017 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 35 increasing their positions, 29 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
7% more funds holding
Funds holding: 101 → 108 (+7)
2.73% more ownership
Funds ownership: 65.48% → 68.21% (+2.7%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
108
Holding in Top 10
1
Calls
$4.32M
Puts
$626K
Top Buyers
| 1 | +$39M | |
| 2 | +$5.87M | |
| 3 | +$4.3M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.44M |
| 5 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
+$2.76M |
Top Sellers
| 1 | -$7.59M | |
| 2 | -$2.56M | |
| 3 | -$2.3M | |
| 4 |
GC
Globeflex Capital
San Diego,
California
|
-$1.69M |
| 5 |
D.E. Shaw & Co
New York
|
-$1.11M |